Autobahn Therapeutics, Inc.
Clinical trials sponsored by Autobahn Therapeutics, Inc., explained in plain language.
-
New drug shows promise for bipolar depression in early trial
Symptom relief Recruiting nowThis study tests whether adding a new drug called ABX-002 to current treatments can improve depression symptoms in adults with bipolar disorder. About 30 people with bipolar depression will take the drug for 6 weeks, and some will have brain scans to see how it affects brain chem…
Phase: PHASE2 • Sponsor: Autobahn Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 07:55 UTC
-
New depression pill hopes to lift the fog for those failed by antidepressants
Symptom relief Recruiting nowThis study tests whether adding ABX-002 to current antidepressant medication can better reduce depression symptoms in adults with moderate to severe major depressive disorder who haven't responded well enough to their existing treatment. About 230 participants will receive either…
Phase: PHASE2 • Sponsor: Autobahn Therapeutics, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC